#1 Clinical Trials Search in Europe

Cefixime

Cefixime, a third-generation cephalosporin antibiotic, is being studied in various clinical trials to evaluate its effectiveness in treating different infections and explore new treatment regimens. These trials aim to assess cefixime’s potential as an alternative treatment option, its efficacy in combination with other antibiotics, and its pharmacokinetics in different dosing schedules. The research spans multiple conditions, including gonorrhea, syphilis, typhoid fever, and liver abscesses, providing valuable insights into cefixime’s broader applications in infectious disease management.

Table of Contents

What is Cefixime?

Cefixime is an antibiotic medication that belongs to a class of drugs called cephalosporins. It is specifically a third-generation cephalosporin, which means it is a more advanced and broad-spectrum antibiotic compared to earlier generations[1]. Cefixime is available under various brand names, including Suprax[2].

Uses of Cefixime

Cefixime is used to treat a variety of bacterial infections. Some of the conditions it can treat include:

  • Gonorrhea: A sexually transmitted infection that affects the genitals, rectum, and throat[3]
  • Syphilis: Another sexually transmitted infection that can cause serious health problems if left untreated[2]
  • Typhoid fever: A bacterial infection that causes high fever, stomach pain, and other symptoms[4]
  • Urinary tract infections: Infections that affect the bladder, kidneys, or other parts of the urinary system[1]
  • Respiratory tract infections: Such as acute bronchitis[1]
  • Otitis media: A middle ear infection[1]
  • Liver abscess: A pus-filled pocket of fluid within the liver[5]

How Cefixime Works

Cefixime works by inhibiting the action of proteins involved in the synthesis of bacterial cell walls. This leads to the weakening and eventual breakdown of the bacterial cell wall, causing the bacteria to die[1]. This mechanism makes cefixime effective against a wide range of bacteria, including both gram-positive and gram-negative bacteria.

Dosage and Administration

Cefixime is typically taken orally in the form of tablets, capsules, or as a liquid suspension. The dosage and duration of treatment can vary depending on the specific condition being treated and the patient’s age and weight. Some common dosage forms include:

  • 400 mg tablets or capsules[3]
  • 200 mg tablets[4]
  • 100 mg/5 mL dry syrup (which needs to be reconstituted with water before use)[6]

It’s important to follow your doctor’s instructions carefully when taking cefixime. The medication is often prescribed to be taken once or twice daily, depending on the condition being treated.

Ongoing Research

Cefixime is currently being studied for various uses and in different combinations with other antibiotics. Some ongoing research includes:

  • High-dose cefixime for gonorrhea: Researchers are investigating whether higher doses of cefixime (800 mg) can be effective against gonorrhea strains that have decreased susceptibility to antibiotics[3].
  • Combination therapy for typhoid fever: Studies are exploring the use of cefixime in combination with azithromycin for the treatment of typhoid fever[4].
  • Alternative treatment for syphilis: Cefixime is being evaluated as a potential alternative to penicillin for treating syphilis, especially in cases of penicillin allergy or shortage[2].
  • Treatment for liver abscess: The effectiveness of cefixime in combination with metronidazole is being compared to other antibiotic combinations for treating liver abscesses[5].

Side Effects

Like all medications, cefixime can cause side effects. Common side effects may include:

  • Diarrhea
  • Nausea
  • Stomach pain
  • Headache
  • Dizziness

More serious side effects, though rare, can occur. These may include severe allergic reactions, Clostridium difficile-associated diarrhea (a type of severe diarrhea caused by an overgrowth of harmful bacteria), and changes in blood cell counts. If you experience any unusual or severe side effects while taking cefixime, contact your healthcare provider immediately[3].

Aspect Details
Conditions Studied Gonorrhea, Syphilis, Typhoid fever, Liver abscesses, Bacterial vaginitis/cervicitis
Dosing Regimens Single high doses (800 mg), Multiple doses (400 mg twice daily for 10 days), Extended high-dose regimens (800 mg every 8 hours for 3 doses)
Combination Therapies Cefixime + Doxycycline, Cefixime + Metronidazole, Cefixime + Azithromycin
Comparison Treatments Penicillin, Ceftriaxone + Azithromycin, Benzathine Penicillin G
Main Outcomes Measured Treatment efficacy, Pharmacokinetics, Safety and tolerability, Comparative effectiveness
Study Designs Randomized controlled trials, Non-inferiority trials, Pharmacokinetic studies, Bioequivalence studies
Patient Populations Adults with various infections, including special populations (e.g., HIV-positive individuals)

FAQ

  • What conditions are being studied with cefixime in clinical trials? Clinical trials are exploring cefixime's effectiveness in treating various conditions, including gonorrhea, syphilis, typhoid fever, liver abscesses, and bacterial vaginitis/cervicitis.
  • How is cefixime being compared to standard treatments in these trials? Cefixime is being compared to standard treatments like penicillin for syphilis, ceftriaxone plus azithromycin for gonorrhea, and benzathine penicillin G for early syphilis. These comparisons help determine if cefixime can be an effective alternative treatment option.
  • What dosing regimens of cefixime are being studied? Various dosing regimens are being studied, including single high doses (800 mg), multiple doses over several days (e.g., 400 mg twice daily for 10 days), and extended duration high-dose regimens (e.g., 800 mg every 8 hours for 3 doses).
  • Are there any combination therapies involving cefixime being tested? Yes, several trials are testing combination therapies. For example, cefixime plus doxycycline for gonorrhea treatment, cefixime plus metronidazole for liver abscesses, and cefixime plus azithromycin for typhoid fever.
  • What are the main outcomes being measured in these cefixime trials? The main outcomes being measured include treatment efficacy (e.g., clinical cure rates, microbiological cure rates), pharmacokinetics (e.g., drug levels in blood and tissues), safety and tolerability, and comparison of effectiveness to standard treatments.

Ongoing Clinical Trials on Cefixime

  • Study on the Effectiveness of Fosfomycin, Cefixime, and Ciprofloxacin in Treating Acute Bacterial Prostatitis in Adult Men

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Testing Antibiotic Treatment Strategies for Patients with Bladder Bacteria Without Symptoms Receiving Botulinum Toxin A Bladder Injections

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • A Study Comparing How the Body Absorbs Cefixime in Healthy Volunteers

    Not recruiting

    1 1 1
    Investigated drugs:
    Romania

Glossary

  • Cefixime: A third-generation cephalosporin antibiotic used to treat various bacterial infections. It works by inhibiting bacterial cell wall synthesis.
  • Pharmacokinetics (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and have the same rate and extent of absorption.
  • Empiric therapy: Treatment given based on clinical experience before a definitive diagnosis is made, often used in infectious diseases.
  • Mucopurulent cervicitis (MPC): An inflammation of the cervix characterized by a discharge containing both mucus and pus.
  • Rapid Plasma Reagin (RPR): A blood test used to screen for syphilis by detecting antibodies to the bacterium that causes the disease.
  • Minimum Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that prevents visible growth of a bacterium.
  • Area Under the Curve (AUC): A measure of the total exposure to a drug over time, used in pharmacokinetic studies.
  • Neisseria gonorrhoeae: The bacterium that causes gonorrhea, a sexually transmitted infection.
  • Enteric fever: A systemic illness caused by Salmonella typhi or Salmonella paratyphi, also known as typhoid or paratyphoid fever.

References

  1. https://clinicaltrials.gov/study/NCT03329547
  2. https://clinicaltrials.gov/study/NCT03660488
  3. https://clinicaltrials.gov/study/NCT01949363
  4. https://clinicaltrials.gov/study/NCT04349826
  5. https://clinicaltrials.gov/study/NCT03969758
  6. https://clinicaltrials.gov/study/NCT04982861